Mark J Rosenblum insider trades: Salarius Pharmaceuticals (SLRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | SLRX | ↑ Buy | 20,000 | $0.80 | $16K | Direct | Nov 20, 2025 (0d) |
| May 31, 2022 | SLRX | ↑ Buy | 28,000 | $0.18 | $5K | Direct | May 31, 2022 (0d) |
| Mar 3, 2022 | SLRX | ↑ Buy | 76,246 | $0.39 | $30K | Direct | Mar 9, 2022 (6d) |
| Aug 17, 2020 | SLRX | ↑ Buy | 5,000 | $1.00 | $5K | Direct | Aug 18, 2020 (1d) |
| Feb 19, 2020 | SLRX | ↑ Buy | 2,000 | $0.95 | $2K | Direct | Feb 20, 2020 (1d) |
| Feb 13, 2020 | SLRX | ↑ Buy | 5,000 | $0.86 | $4K | Direct | Feb 13, 2020 (0d) |
| Oct 24, 2013 | ADXS | ↑ Buy | 12,000 | $4.00 | $48K | Direct | Oct 28, 2013 (4d) |
| Nov 21, 2005 | HMBT | ↑ Buy | 2,000 | $1.50 | $3K | Direct | Nov 23, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLRX insiders
Open-market trades in the last 12 months
About Mark J Rosenblum's insider trades
Mark J Rosenblum is Exec VP Finance, CFO at Salarius Pharmaceuticals (SLRX). Since Nov 21, 2005, Mark has reported 8 open-market purchases worth $113K and no sales on SEC Form 4. In the last 12 months: 1 buy ($16K).
Their filings also include grants and awards (26 filings), shares withheld for taxes (3 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.